Drazen Rahelić

Drazen Rahelić

Auto-generated profile, based on publicly available information

Drazen Rahelić

Department of Urology, University Hospital Rijeka, Rijeka, Croatia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2014 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
DMDEAN MARKIĆ
DEAN MARKIĆ
AMAnton Maričić
Anton Maričić
RORomano Oguić
Romano Oguić
Josip SpanjolJosip Spanjol
Josip Spanjol
DRDražen Rahelić
Dražen Rahelić
MVMaksim Valenčić
Maksim Valenčić

1 July 2017 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
PDF file
DMDEAN MARKIĆ
DEAN MARKIĆ
BVBožidar Vujičić
Božidar Vujičić
MIMladen Ivanovski
Mladen Ivanovski
KKKristian Krpina
Kristian Krpina
AGAntun Gršković
Antun Gršković
SRSanjin Rački
Sanjin Rački
Background: Peritoneal dialysis (PD) catheter surgery can be performed using regional anesthesia. We present our PD catheter placement and extraction experience using ultrasound-guided transversus abdominis plane (TAP) block. Methods: In the present study, we analyzed 74 patients from our center with end-stage renal disease (ESRD) who underwent PD catheter placement (60 patients) and removal (14 patients) using a TAP block between June 2011 and December 2015. Results: The TAP block was successful for 55/60 (91.7%) patients (insertion) and 13/14 (92.9%) patients (extraction). Other patients had pain at the incision site and required general anesthesia. There were no anesthesia-, surgery- or PD catheter-related complications. Conclusion: The TAP block is a safe and effective technique not only for high-risk ESRD patients but for all patients undergoing PD catheter placement or extraction.

Verified
Journal Article
Closed access
PDF file
KKKristian Krpina
Kristian Krpina
DMDEAN MARKIĆ
DEAN MARKIĆ
DRDražen Rahelić
Dražen Rahelić
JAJuraj Ahel
Juraj Ahel
NRNino Rubinić
Nino Rubinić
Josip SpanjolJosip Spanjol
Josip Spanjol
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease.

1 December 2014
Verified
Journal Article
Closed access
AMAnton Maricić
Anton Maricić
SSStanislav Sotosek
Stanislav Sotosek
DMDEAN MARKIĆ
DEAN MARKIĆ
Josip SpanjolJosip Spanjol
Josip Spanjol
KKKristian Krpina
Kristian Krpina
MMMauro Materljan
Mauro Materljan

1 April 2010
Verified
Journal Article
Closed access
AMAnton Maricić
Anton Maricić
MVMaksim Valencić
Maksim Valencić
RORomano Oguić
Romano Oguić
DRDrazen Rahelić
Drazen Rahelić
KKKristian Krpina
Kristian Krpina
MMMauro Materljan
Mauro Materljan

1 April 2010
Verified
Journal Article
Closed access
MVMaksim Valencić
Maksim Valencić
AMAnton Maricić
Anton Maricić
RORomano Oguić
Romano Oguić
DRDrazen Rahelić
Drazen Rahelić
SSStanislav Sotosek
Stanislav Sotosek
AGAntun Gršković
Antun Gršković